about
Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination Therapies.Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics.New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis.Safety and efficacy of mizoribine in patients with connective tissue diseases other than rheumatoid arthritis.Mizoribine as a safe and effective combined maintenance therapy with prednisolone for anti-neutrophil cytoplasmic antibody-associated vasculitis in a hemodialysis patient.Mizoribine protects against bleomycin-induced lung injury.Mizoribine therapy in a patient with lupus nephritis: the association between mizoribine concentration and peritoneal dialysis.Impact of concentrative nucleoside transporter 1 gene polymorphism on oral bioavailability of mizoribine in stable kidney transplant recipients.Identification of an inhibitor of hsc70-mediated protein translocation and ATP hydrolysis.Effect of mycophenolate mofetil on the progression of adriamycin nephropathy.Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy.Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.Use of mizoribine as a rescue drug for steroid-resistant pediatric IgA nephropathy.Efficacy of steroid pulse, plasmapheresis, and mizoribine in a patient with focal segmental glomerulosclerosis.The effectiveness of new triple combination therapy using synthetic disease-modifying anti-rheumatic drugs with different pharmacological function against rheumatoid arthritis: the verification by an in vitro and clinical study.Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.Cyclosporine A and tacrolimus combined with enteric-coated mycophenolate sodium influence the plasma mycophenolic acid concentration - a randomised controlled trial in Chinese live related donor kidney transplant recipients.
P2860
Q32182492-ACB1D5AD-B53E-427C-84F2-B6330E55FCA7Q37148784-58FDB5C3-C99F-4473-9D95-C49DB9A5CAC2Q37696576-5CF49D38-73C5-4811-B9F8-3C02DA02A499Q38071246-08B4A058-37F6-4F7E-B281-7640BF23394DQ38783573-9B6BD125-0541-4463-A90F-81A39EC57392Q43057630-990095D9-0AA9-48F2-AF57-6A2BB0E67223Q43191395-EDEA3D4A-E452-49DE-9624-EC933013CC9CQ43242691-F2042D80-0A31-4B6B-AD1B-CB84097C61FDQ43508426-C34A8BD8-4B04-42FB-8BCB-4F2AB7B0D793Q43810613-28325682-E066-4A62-AC39-E7B95B808ECAQ45154863-90DE0D4F-7E5A-4912-AFF1-E8618916D087Q46617730-3EEB0EE6-2409-4F82-8980-3E17AB1D78FBQ46833115-ECC15A23-5089-4524-895E-F6DCC7F71EBCQ46882444-05438076-35D6-4D32-AF57-A49A1ED2753AQ48249248-59471AF7-89E3-4D1D-BDEE-CE6FDB736D08Q51362330-D2399804-BFC1-4014-A2A9-811B1A8BAD22Q52709504-F1952142-50B7-47F0-A6DA-F9959B2F920FQ53791202-A1944244-CE92-457C-B55E-BD0E1503BABB
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
New immunosuppressive drugs in organ transplantation.
@en
type
label
New immunosuppressive drugs in organ transplantation.
@en
prefLabel
New immunosuppressive drugs in organ transplantation.
@en
P2860
P1476
New immunosuppressive drugs in organ transplantation.
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1996.TB04160.X
P577
1996-12-01T00:00:00Z